Effectiveness, feasibility, and acceptability of a novel family practice-based integrative care model for family caregivers of dementia patients

ISRCTN ISRCTN55348828
DOI https://doi.org/10.1186/ISRCTN55348828
Secondary identifying numbers AD_HOC_01
Submission date
21/09/2021
Registration date
12/10/2021
Last edited
12/10/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Dementia is a major burden for those affected and their family caregivers. The number of patients with dementia is increasing as a result of demographic developments. Involving family caregivers in the care of persons with dementia is essential. Family caregivers of individuals of dementia may be key players, but their multiple tasks often make them overburdened, depressed, and themselves multimorbid.
The aim of this study is to evaluate an integrated care model for family caregivers of individuals with dementia with respect to a) its effect on caregiver burden and b) practicability in Swiss primary care.

Who can participate?
Family caregivers of individuals with cognitive impairment.

What does the study involve?
Participating physicians and practice assistants (German: "Medizinische Praxisfachpersonen"; MPFPs) will be trained in the management of older patients with dementia. Subsequently, key family caregivers of individuals with dementia will be recruited in the setting of primary care. The coaching of these family caregivers will initially be 2-weekly, later 6-weekly - in four visits. In form of a questionnaire, the participating professional groups (MPFPs and physicians) will evaluate the intervention process. The family caregivers will evaluate the intervention process in form of a questionnaire and telephone interview.

What are the possible benefits and risks of participating?
The study intervention does not pose any additional risk to the participants and is expected to increase the participants' quality of life.

Where is the study run from?
The Institute of Primary Care of the University Hospital Zurich runs the study together with the Department of Health Science and Medicine of the University of Lucerne, Switzerland.

When is the study starting and how long is it expected to run for?
January 2021 to June 2024

Who is funding the study?
The study is partly funded by Alzheimer Schweiz (https://www.alzheimer-schweiz.ch) (Switzerland).

Who is the main contact?
1. Prof. Dr. Stefan Neuner-Jehle MPH (stefan.neuner-jehle@usz.ch)
2. Gino Bopp (gino.bopp@usz.ch)

Contact information

Prof Stefan Neuner-Jehle MPH
Scientific

Institute of Primary Care
University and University Hospital of Zurich
Pestalozzistrasse 24
Zurich
8091
Switzerland

ORCiD logoORCID ID 0000-0002-6260-8148
Phone +41 (0)44 255 98 55
Email stefan.neuner-jehle@usz.ch
Mr Gino Bopp
Scientific

Institute for Primary Care
University and University Hospital Zurich
Pestalozzistrasse 24
Zurich
8091
Switzerland

ORCiD logoORCID ID 0000-0003-2517-0260
Phone +41 (0)44 255 85 09
Email gino.bopp@usz.ch

Study information

Study designSuperiority trial with a prospective nonclinical one-group pre-post-design
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Home
Study typeQuality of life
Participant information sheet 40458 PIS v2 14July2021.pdf
Scientific titleAlzheimer's disease - HOme visit support for family Caregivers
Study acronymAD HOC-Study
Study objectives1. Home assistance and support for family caregivers of persons with cognitive impairment leads to a stabilization of the burden or even to a reduced burden of these persons after 6 months (T6) compared to "usual care".
2. The model of care developed in this study integrates well with the primary care outpatient setting.
Ethics approval(s)Health services research not required to be approved. Confirmed by University of Zurich. Req-2021-00280
Health condition(s) or problem(s) studiedSupport for family caregivers of people with cognitive impairment in primary care.
InterventionFamily caregivers are coached initially on a 2-weekly basis, later on a 6-weekly basis - in four visits (= outreach) and two telephone calls. In the initial visit, practice assistants (German: "Medizinische Praxisfachperson"; MPFPs) systematically explore the family caregivers' current problems and stresses as well as their priority needs and objectives. On that basis, recommendations are developed and regional care services are selected. During the next visit/telephone call, the results of the exploration and the recommendations are reflected on together with the family caregivers and the specific next steps are defined. The MPFP use an interview guide to ensure the best possible standardization of the intervention.
The intervention phase including the follow-up period will take place between 01 January 2022 to 01 January 2024 (updated 08/08/2022, previously: to 31 December 2022)
Intervention typeBehavioural
Primary outcome measureThe burden of care, assessed using the ZBI (Zarit Burden Inventory) at the first home visit at T0 (baseline) and the last home visit at T5 (6 months after T0).
Secondary outcome measures1. Change in the ZBI score of family caregivers between T0 and T6 (9 months after T0).
2. Change in quality of life, assessed using the EQ-5D-5L instrument, of family caregivers between T0 and T5.
3. Changes in quality of life of family caregivers between T0 and T6 (follow-up).
4. Health care utilization by dementia patients under care: Institutionalization, hospitalizations, medical consultations, emergency medical consultations, emergency department visits.
Overall study start date01/01/2021
Completion date01/06/2024

Eligibility

Participant type(s)Carer
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants30-40
Key inclusion criteria1. Age ≥18 years
2. Family caregiver of individuals with cognitive functional impairment ("Alzheimer's Disease", "Dementia" or "Development of a cognitive disorder")
3. Person who: 1) is perceived by the study physician/MPFP to be the key informal family caregiver of the index patient or, 2) is identified by the index patient as a key informal family caregiver or, 3) is identified by others (professional caregivers, legal representatives, family members) as the key informal family caregiver.
Key exclusion criteria1. Presence of cognitive impairment
2. Insufficient language ability in German
3. Moribund case of the family caregiver or the index patient with a remaining life expectancy of <3 months
Date of first enrolment01/06/2022
Date of final enrolment01/12/2023

Locations

Countries of recruitment

  • Switzerland

Study participating centre

Institute of Primary Care
University and University Hospital of Zurich
Pestalozzistrasse 24
Zurich
8091
Switzerland

Sponsor information

University and University Hospital of Zurich
Research organisation

Prof. Dr. Stefan Neuner-Jehle MPH
Institute of Primary Care
Pestalozzistrasse 24
Zurich
8091
Switzerland

Phone +41 44 255 98 55
Email stefan.neuner-jehle@usz.ch
Website http://www.hausarztmedizin.uzh.ch/

Funders

Funder type

Charity

Alzheimer Schweiz (www.alzheimer-schweiz.ch)

No information available

Results and Publications

Intention to publish date01/06/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal.
IPD sharing planAll data generated or analysed during this study will be included in the subsequent results publication.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version 2 14/07/2021 06/10/2021 No Yes

Additional files

40458 PIS v2 14July2021.pdf

Editorial Notes

12/10/2022: Contact details updated.
04/10/2022: Contact details updated.
20/09/2022: Contact details updated.
08/08/2022: The interventions were changed.
03/08/2022: The following changes were made to the trial record:
1. The recruitment start date was changed from 01/03/2022 to 01/06/2022.
2. The recruitment end date was changed from 30/09/2022 to 01/12/2023.
3. The overall end date was changed from 30/06/2023 to 01/06/2024.
4. The intention to publish date was changed from 01/06/2023 to 01/06/2024.
5. The plain English summary was updated to reflect these changes.
27/01/2022: The following changes have been made:
1. The recruitment start date has been changed from 01/01/2022 to 01/03/2022.
2. The recruitment end date has been changed from 30/06/2022 to 30/09/2022.
3. The overall trial end date has been changed from 31/03/2023 to 30/06/2023 and the plain English summary has been updated accordingly.
06/10/2021: Trial's existence confirmed by University of Zurich.